X
<

Key Updates on ZBH Stock for Investors

PART:
1 2 3 4 5
Part 5
Key Updates on ZBH Stock for Investors PART 5 OF 5

How Has ZBH Stock Performed Recently?

ZBH’s stock performance

Zimmer Biomet Holdings (ZBH) has fallen around 0.8% over the last one week. Over the last one month, the stock registered returns of around 3.7%. ZBH stock was trading at a closing price of $115.5 on September 19, 2017. The stock is currently trading higher than its 50-day moving average of $114.50 and lower than its 200-day moving average of $120.75. The stock’s 52-week low of $95.63 was reported on November 14, 2016, while its 52-week high of $133.49 was registered on July 17, 2017.

How Has ZBH Stock Performed Recently?

Interested in ABT? Don't miss the next report.

Receive e-mail alerts for new research on ABT

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.

Since its latest earnings release on July 27, 2017, when the company reported lower-than-expected earnings results, ZBH stock has fallen 10.3%. On the day, ZBH stock had lost around 25% due to the disappointing results. Also, on the 1Q17 earnings release, ZBH stock lost around 6% on account of the lowered full-year 2017 guidance. The results, however, exceeded estimates. The company had received a subpoena from the US Health & Human Services Department on August 9, 2017. The stock fell around 2% on the day.

As of September 19, 2017, peers Medtronic (MDT), Abbott Laboratories (ABT), and Stryker (SYK) have generated returns of about -8.2%, 13%, and 16.7%, respectively, over the last one year.

Comparisons with industry and market performances

Zimmer Biomet Holdings has registered a decline of around 7.1% in its stock price over the past 12 months. If we compare the stock performance with that of the market, as represented by the SPDR S&P 500 Index (SPY), we can see that the ZBH stock underperformed the market by high proportions. SPY has registered a price rise of around 17.1% in the past 12 months.

Let’s consider the industry performance over the same period. The iShares US Medical Devices ETF (IHI) returned ~17.6% over the past one year. However, on a YTD (year-to-date) basis, ZBH stock has performed at par with the broader market but has largely underperformed the industry. ZBH stock rose around 11.9% on a YTD basis as compared to the approximately 11.9% and 26.1% returns registered by the SPY and IHI, respectively, over the same period.

X

Please select a profession that best describes you: